Results 141 to 150 of about 45,078 (268)

Assessment of the influence of ABO blood groups on oral cholera vaccine immunogenicity in a cholera endemic area in Zambia. [PDF]

open access: yesBMC Public Health, 2023
Chisenga CC   +9 more
europepmc   +1 more source

Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults

open access: green, 1989
S Migasena   +9 more
openalex   +1 more source

Comparison of O-specific polysaccharide responses in patients following infection with Vibrio cholerae O139 versus vaccination with a bivalent (O1/O139) oral killed cholera vaccine in Bangladesh. [PDF]

open access: yesmSphere, 2023
Kaisar MH   +17 more
europepmc   +1 more source

Albendazole Treatment of Children with Ascariasis Enhances the Vibriocidal Antibody Response to the Live Attenuated Oral Cholera Vaccine CVD 103‐HgR [PDF]

open access: bronze, 2000
Philip J. Cooper   +11 more
openalex   +1 more source

Challenges for Programmatic Implementation of Oral Cholera Vaccine in India. [PDF]

open access: yesJ Infect Dis, 2021
Chakraborty D   +5 more
europepmc   +1 more source

Impaired mucosal antibody response to cholera toxin in vitamin A-deficient rats immunized with oral cholera vaccine

open access: bronze, 1993
Ursula Wiedermann   +4 more
openalex   +1 more source

An Age-stratified, Randomized Immunogenicity Trial of Killed Oral Cholera Vaccine with Delayed Second Dose in Cameroon. [PDF]

open access: yesAm J Trop Med Hyg, 2022
Ateudjieu J   +15 more
europepmc   +1 more source

Construction and Characterization of a Nonproliferative El Tor Cholera Vaccine Candidate Derived from Strain 638 [PDF]

open access: green, 2000
Edgar Valle   +10 more
openalex   +1 more source

Development of Pediatric Dosage Preparation for CVD 103-HgR Live Oral Cholera Vaccine. [PDF]

open access: yesAm J Trop Med Hyg, 2022
Duffin RP   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy